Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Castle Biosciences to Present at Upcoming Investor Conferences


Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that Derek Maetzold, president and chief executive officer, will present at the following upcoming investor conferences:

Live audio webcasts of the company's presentations will be available by visiting Castle Biosciences' website at https://ir.castlebiosciences.com/news-events/events-presentations. A replay of the webcast will be available for two weeks following the conclusion of the live broadcast.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq; www.SkinMelanoma.com) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq; www.MyUvealMelanoma.com), with products in development for other underserved cancers, the two most advanced of which are focused on patients with cutaneous squamous cell carcinoma, and patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona. For more information, visit www.CastleBiosciences.com.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.


These press releases may also interest you

at 13:15
A new study that has the potential to eliminate the future need for dialysis discovers that it is possible to rejuvenate kidneys and improve their function by using the patient's own stem cells. This groundbreaking study was conducted by Professor...

at 13:10
The fourth quarter of 2019 kicked off a new collaboration between Empower Brokerage and Oppenheimer & Company, Inc. in New York. Oppenheimer is a leading global full-service brokerage and investment bank with over a century of tradition. They have a...

at 13:05
B. Riley FBR, Inc., a full service investment bank and subsidiary of B. Riley Financial, Inc. , today announced that its 21st Annual Institutional Investor Conference will take place May 19th - 21st, 2020 at The Beverly Hilton in Beverly Hills,...

at 13:00
The Assistance Fund (TAF), an independent, charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with...

at 13:00
GenCare Lifestyle at Point Ruston, a wellness-focused, 159-apartment retirement community at Point Ruston announced today an innovative partnership to improve the health and wellness of active adults in the South Sound....

at 12:47
Eli Lilly and Company , a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs in Durham, Governor Roy Cooper announced today.  The project will bring a new state-of-the-art pharmaceutical...



News published on 20 november 2019 at 07:05 and distributed by: